STUDY OF MORTALITY PATTERNS IN YOUNG PATIENTS: UNCOVERING THE ORIGINS OF TROPONIN ELEVATION

Main Article Content

Dr. Muhammad Shehbaz
Dr. Syed Sibtain ul Hassan
Dr. Jehanzaib Motlani
Dr Tahreem Lodhi
Dr. Muhammad Zohaib Qasim
Dr. Muhammad Hamza Tahir
Dr. Saira Tasawar
Dr. Muhammad Adeel Zafar
Dr Shahrukh Rehman
Intsar Ali jatala

Keywords

troponin, young adults, Pakistan. End stage renal disease

Abstract

Purpose: Myocardial infarction is one clinical condition in which serum levels of troponin may increase. In older populations, these sources of troponin rise have been extensively investigated, whereas in younger populations, fewer studies have been conducted.


Methodology: From June 2021 to June 2023, a retrospective analysis was conducted on individuals younger than 65 years old who presented with elevated blood troponin levels at two large tertiary care facilities. Those with coronary artery disease were excluded from the study. Using electronic medical records, the rise in troponin's cause was determined. The Social Security Administration recorded all-cause mortality in its death master file.


Results: There were 693 (64.1%) myocardial infarctions among the 1081 individuals who satisfied the inclusion criteria, whereas 388 (35.9%) had increased troponin levels due to other medical problems. After 2.5 years, patients whose troponin levels increased for reasons other than myocardial infarction had a greater risk of all-cause death. Central nervous system diseases, non-ischemic cardiomyopathies, and end-stage renal illness all increased mortality. Acute myocardial infarction was related with a higher death rate than myocarditis.


Conclusion: Numerous demographic factors contribute to the rise in troponin levels among younger individuals. Acute myocardial infarction has a lower mortality rate than other conditions that increase troponin levels.

Abstract 219 | pdf Downloads 85

References

1. Snipelisky D, Donovan S, Levy M, Satyanarayana R, Shapiro B. Cardiac Troponin Elevation Predicts Mortality in Patients Undergoing Orthotopic Liver Transplantation. Journal of Transplantation. 2013;2013:1–6.
2. Tamis‐Holland JE, Jneid H. Myocardial Infarction With Nonobstructive Coronary Arteries (MINOCA): It’s Time to Face Reality! Journal of the American Heart Association. 2018 Jul 3;7(13).
3. Dhesi S, Shanks M, Tymchak WJ. Troponin Rise in Hospitalized Patients With Nonacute Coronary Syndrome: Retrospective Assessment of Outcomes and Predictors. Canadian Journal of Cardiology. 2015 Mar;31(3):296–301.
4. Korley FK, Schulman SP, Sokoll LJ, DeFilippis AP, Stolbach A, Bayram JD, et al. Troponin Elevations Only Detected With a High-sensitivity Assay: Clinical Correlations and Prognostic Significance. 2014 Jul 1;21(7):727–35.
5. Anders B, Alonso A, Artemis D, Schäfer A, Ebert A, Kablau M, et al. What Does Elevated High-Sensitive Troponin I in Stroke Patients Mean: Concomitant Acute Myocardial Infarction or a Marker for High-Risk Patients. Cerebrovascular Diseases. 2013;36(3):211–7.
6. Umeh CA, Sobiga Ranchithan, Watanabe K, Tuscher L, Gupta R. Elevated Troponin and Mortality in Patients with COVID-19: A Multicenter Retrospective Cohort Study. 2022 Sep 26;16(1).
7. Ashraf T. UNDERSTANDING TROPONINS: HOW IMPORTANT IT IS. Pakistan Heart Journal [Internet]. 2022 Jul 5 [cited 2023 Jul 14];55(2):99–100. Available from: https://pakheartjournal.com/index.php/pk/article/view/2339
8. Kumar P, Saifullah N, Akhter S. Effect of Raised Cardiac Troponin Levels on Inpatient Mortality in Patients with Community Acquired Pneumonia. Liaquat National Journal of Primary Care. 2022;
9. Salman M, Abbas Khan M, Yousaf M, Inam-U-llah, Hussain M, Sarfraz A. Frequency and Extent of Multivessel Coronary Artery Disease in Patients with Non St-Segment Elevation Myocardial Infarction (Nstemi)With Raised Cardiac Troponin-T (CTNT). Pakistan Journal of Health Sciences [Internet]. 2023 Jan 31 [cited 2023 May 27];171–4. Available from: https://www.thejas.com.pk/index.php/pjhs/article/download/508/335
10. Mahajan VS, Jarolim P. How to Interpret Elevated Cardiac Troponin Levels. Circulation [Internet]. 2011 Nov 22;124(21):2350–4. Available from:
https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.111.023697
11. Mushtaque I, Awais-E-Yazdan M, Zahra R, Anas M. Quality of Life and Illness Acceptance among End-Stage Renal Disease (ESRD) Patients on Hemodialysis: The Moderating Effect of Death Anxiety during COVID-19 pandemic. OMEGA - Journal of Death and Dying. 2022 Mar 7;003022282210752.
12. Hayat A, Munir U, Iqbal Z, Mahmood H, Anwer K, Afshan S. Troponin T and Cardiac Enzyme Levels since Onset of Chest Pain in Patients Suspected of Acute Myocardial Infarction (AMI) in Punjab, Pakistan. Pakistan Journal of Medical and Health Sciences. 2022 Aug 31;16(8):254–7.
13. Kaura A, Panoulas V, Glampson B, Davies J, Mulla A, Woods K, et al. Association of troponin level and age with mortality in 250 000 patients: cohort study across five UK acute care centres. BMJ: British Medical Journal [Internet]. 2019 [cited 2023 Jul 14];367:1–11. Available from: https://www.jstor.org/stable/27178552
14. Lorson W, Veve MP, Heidel E, Shorman M. Elevated troponin level as a predictor of inpatient mortality in patients with infective endocarditis in the Southeast United States. BMC Infect Dis. 2020 Jan 8;20(1).
15. Thoker ZA, Khan KA, Rashid I, Zafar. Correlation of cardiac troponin I levels with infective endocarditis & its adverse clinical outcomes. International Journal of Cardiology. 2016 Nov;222:661–4.
16. Vrsalovic M, Vrsalovic Presecki A, Aboyans V. Cardiac troponins predict mortality and cardiovascular outcomes in patients with peripheral artery disease: A systematic review and meta‐analysis of adjusted observational studies. Clinical Cardiology. 2022 Feb;45(2):198–204.
17. Eisen A, Bonaca MP, Petr Jarolim, Scirica BM, White HD, Tendera M, et al. High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial. Clinical Chemistry. 2017 Jan 1;63(1):307–15.

Most read articles by the same author(s)